Level Biotechnology (3118)

TPEX

Currency in TWD

31.90

+0.50(+1.59%)

Closed·01/09

Fair Value

Unlock Value

Day's Range

31.40

32.00

52 wk Range

30.85

34.70

3118 Income Statement

Assess the Level BioTech income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 3118 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

677.28

593.01

660.61

731.35

736.59

Total Revenues Growth

aa.aa

+0.71%

-12.44%

+11.4%

+10.71%

+0.72%

Cost Of Revenues

aa.aa

444.78

390.42

441.07

494.22

478.9

Gross Profit

aa.aa

232.5

202.59

219.55

237.13

257.7

Gross Profit Growth

aa.aa

+9.82%

-12.87%

+8.37%

+8.01%

+8.67%

Gross Profit Margin %

aa.aa

34.33%

34.16%

33.23%

32.42%

34.99%

Other Operating Expenses, Total

aa.aa

153.54

137.69

151.99

161.81

174.15

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.31%	-10.32%	+10.39%	+6.46%	+7.63%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	15.02	14.03	13.77	12.95	13.7
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	138.52	123.66	138.22	148.86	160.45
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

78.96

64.9

67.55

75.32

83.55

Operating Income Growth

aa.aa

+19.8%

-17.81%

+4.08%

+11.5%

+10.92%

EBIT Margin %

aa.aa

11.66%

10.94%

10.23%

10.3%

11.34%

Net Interest Expenses

aa.aa

1.29

2.13

4.85

5.17

3.22

Net Interest Expenses Growth

aa.aa

-17.17%

+65.06%

+128.03%

+6.54%

-37.7%

Interest Expense, Total

aa.aa

-0.38

-0.35

-0.33

-0.28

-0.2

Interest And Investment Income

aa.aa

1.67

2.47

5.18

5.45

3.42

Other Non Operating Expenses, Total

aa.aa

4.77

6.04

6.15

0.62

2.59

EBT, Excl. Unusual Items

aa.aa

85.02

73.07

78.55

81.1

89.36

Gain (Loss) On Sale Of Assets

aa.aa

-0.13

0.08

0.1

0.02

-0

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

84.89

73.16

78.65

81.13

97.58

EBT, Incl. Unusual Items Growth

aa.aa

+17.03%

-13.82%

+7.51%

+3.15%

+20.28%

EBT, Incl. Unusual Items Margin

aa.aa

12.53%

12.34%

11.91%

11.09%

13.25%

Income Tax Expense

aa.aa

16.71

14.69

15.75

16.31

17.88

Net Income to Company

aa.aa

68.18

58.47

62.91

64.81

79.7

Minority Interest

aa.aa

Net Income

aa.aa

68.18

58.47

62.91

64.81

79.7

Net Income Growth

aa.aa

+17.46%

-14.25%

+7.59%

+3.03%

+22.97%

Net Income Margin %

aa.aa

10.07%

9.86%

9.52%

8.86%

10.82%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

68.18

58.47

62.91

64.81

79.7

Basic EPS - Continuing Operations

aa.aa

2.1

1.8

1.94

2.46

Basic EPS - Continuing Operations Growth

aa.aa

+17.46%

-14.25%

+7.59%

+3.03%

+22.97%

Diluted EPS - Continuing Operations

aa.aa

2.09

1.79

1.93

1.99

2.44

Diluted EPS - Continuing Operations Growth

aa.aa

+17.42%

-14.35%

+7.82%

+3.11%

+22.61%

Basic Weighted Average Shares Outstanding

aa.aa

32.45

Diluted Weighted Average Shares Outstanding

aa.aa

32.67

32.66

32.65

32.67

Dividend Per Share

aa.aa

1.9

1.7

1.8

2.2

Dividend Per Share Growth

aa.aa

+18.75%

-10.53%

+5.88%

+22.22%

EBITDA

aa.aa

95.15

80.73

83.21

91.02

100.43

EBITDA Growth

aa.aa

+14.39%

-15.16%

+3.07%

+9.39%

+10.34%

EBITDA Margin %

aa.aa

14.05%

13.61%

12.6%

12.45%

13.63%

EBIT

aa.aa

78.96

64.9

67.55

75.32

83.55

* In Millions of TWD (except for per share items)

FAQ

What was Level BioTech’s revenue at year end?

At the end of the last reported fiscal year, Level BioTech (3118) recorded total revenue of 736.59 million TWD.

How much revenue did Level BioTech report in the most recent quarter?

In its most recent quarterly earnings report, Level BioTech posted revenue of 162.35 million TWD.

What was Level BioTech’s net income for the year?

For the full year, Level BioTech reported net income of 79.70 million TWD.

How much net income did Level BioTech post in the last quarter?

In the most recent quarter, Level BioTech (3118) posted net income of 13.51 million TWD.

What was Level BioTech’s gross profit for the year?

Gross profit for the year was reported at 257.70 million TWD.

How much gross profit did Level BioTech generate last quarter?

Level BioTech recorded gross profit of 55.00 million TWD in its latest quarterly report.

What was Level BioTech’s annual operating income?

For the full year, Level BioTech (3118) reported operating income of 83.55 million TWD.

What was Level BioTech’s operating income last quarter?

Quarterly operating income was 11.96 million TWD.

What was Level BioTech’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 16.51 million TWD.

What was the quarter-over-quarter change in EBITDA for Level BioTech?

EBITDA changed by -31.98% million TWD compared to the last quarter.

What is Level BioTech’s most recent gross profit margin?

The latest reported gross profit margin for Level BioTech (3118) is 33.87% million TWD.

What is Level BioTech’s most recent net income margin?

Net income margin based on recent financials is 8.32% million TWD.

What is Level BioTech’s most recent EBIT margin?

Level BioTech reported an EBIT margin of 7.37% million TWD based on current figures.

How did Level BioTech’s revenue change compared to the previous quarter?

Revenue changed by 2.20% million TWD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Level BioTech?

In the latest quarter, gross profit changed by -7.55% million TWD from the previous quarter.

S&P/TSX

35,961.34

+135.61

+0.38%

S&P/TSX 60

2,113.33

+5.56

+0.26%

US 30

52,991.40

+223.8

+0.42%

US 500

7,663.60

+32.1

+0.42%

S&P 500 VIX

15.24

-1.10

-6.73%

DAX

25,843.34

-126.77

-0.49%

Dollar Index

99.56

-0.077

-0.08%

Market Movers

Name	Last	Chg. %	Vol.
Canadian National Railway	167.35	-0.07%	1.76M
RBC	285.70	+0.91%	952.16K
Toronto Dominion Bank	166.93	+0.42%	1.07M
Hydro One Limited	52.69	-0.88%	3.34M
Bank of Montreal	237.96	+1.61%	685.18K
Canadian Natural	71.87	-0.28%	2.17M
Brookfield Asset Management	69.01	-0.04%	2.14M

Name	Last	Chg. %	Vol.
Patriot Gold	0.10	+533.33%	6.00K
Responsible	1.00	+233.33%	75.07K
Lanebury Growth Capital	0.15	+200.00%	1.00K
Cascadero Copper	0.0250	+150.00%	5.61M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Beckett’s	0.010	+100.00%	4.90K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Global Health Clinics	0.055	-80.00%	500.00
Albert Labs International	0.005	-50.00%	1.00K
Carson River Ventures	0.04	-50.00%	1.25K
Starmet Ventures	0.05	-50.00%	500.00
Molecule Holdings	0.005	-50.00%	20.11K
Ramm Pharma	0.01	-50.00%	1.00K
Treviso Capital	0.02	-42.86%	25.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Canadian Natural	71.87	-0.28%	2.17M
Toronto Dominion Bank	166.93	+0.42%	1.07M
Keel Infra	4.35	+2.11%	1.37M
Whitecap Resources	18.20	-1.28%	3.70M
Hut 8	112.320	+4.03%	209.92K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaa A	32.74	+63.57%	53.55
Aaaaaaaaaaaa	119.00	+54.01%	183.27
Aa A Aa	7.45	+52.69%	11.38
Aaaaa	29.16	+48.75%	43.38
Aaaaaaaaa Aaaaaa	5.30	+46.22%	7.75
Aa Aa Aaaa Aaaaa	9.34	+46.07%	13.64
Aaaa A A Aaaaaaaa Aa	101.14	+45.58%	147.24

Name	Last	Upside	Fair Value
Aaa Aaa A	32.74	+63.57%	53.55
Aaaaaaaaaaaa	119.00	+54.01%	183.27
Aa A Aa	7.45	+52.69%	11.38
Aaaaa	29.16	+48.75%	43.38
Aaaaaaaaa Aaaaaa	5.30	+46.22%	7.75
Aa Aa Aaaa Aaaaa	9.34	+46.07%	13.64
Aaaa A A Aaaaaaaa Aa	101.14	+45.58%	147.24

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Level Biotechnology (3118)

3118 Income Statement

FAQ

What was Level BioTech’s revenue at year end?

How much revenue did Level BioTech report in the most recent quarter?

What was Level BioTech’s net income for the year?

How much net income did Level BioTech post in the last quarter?

What was Level BioTech’s gross profit for the year?

How much gross profit did Level BioTech generate last quarter?

What was Level BioTech’s annual operating income?

What was Level BioTech’s operating income last quarter?

What was Level BioTech’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Level BioTech?

What is Level BioTech’s most recent gross profit margin?

What is Level BioTech’s most recent net income margin?

What is Level BioTech’s most recent EBIT margin?

How did Level BioTech’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Level BioTech?

Trending Stocks